The intraocular lens that was designed and patented by researchers of the Higher Council for Scientific Research (CSIC) has already been successfully implanted in several patients with cataracts, a disease that affects half of the population over 65 years.
The new lens increases the focus range of monofocal lenses that are conventionally used for the treatment of cataracts, CSIC reported today, which has advanced that this new technology will be presented worldwide at the European Society of Surgery Congress Refractive and Waterfalls celebrated from tomorrow in Paris.
The technology designed by CSIC researchers has been implemented in recent weeks in several patients in Spain and the Czech Republic.
The Belgian company Physiol, which has a license for this technology, has commercialized the lens in collaboration with the Laboratory of Visual and Biophotonics Optics of the Institute of Optics "Daza de Valdés" of the Higher Council for Scientific Research.
The researcher Susana Marcos, co-inventor of the lens, recalled that cataracts affect half of the population over 65 years and stressed that cataract surgery involves about 28 million interventions a year.
“In cataract surgery, the natural lens is replaced by an artificial intraocular lens; These lenses have increasingly sophisticated designs that return not only the transparency of the natural lens but also optimize its optical quality, ”explained the researcher in a CSIC press release.
The new intraocular lens increases the focus range of lenses that are conventionally used in the treatment of cataracts, and maintains optimal optical quality for far and intermediate distances, according to the CSIC.
. (tagsToTranslate) Implement (t) first (t) cataracts (t) patented (t) CSIC